All 2,005 procedure codes billed by Medicaid providers in Rhode Island, ranked by total spending.
| # | Code | Description | Total Paid |
|---|---|---|---|
| 1 | T2033 | Residential care, not otherwise specified (nos), waiver; per diem | $877.42M |
| 2 | S5125 | Attendant care services; per 15 minutes | $650.84M |
| 3 | T2017 | Habilitation, residential, waiver; 15 minutes | $381.60M |
| 4 | T2021 | Day habilitation, waiver; per 15 minutes | $330.64M |
| 5 | H0019 | Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem | $242.72M |
| 6 | H0037 | Community psychiatric supportive treatment program, per diem | $217.97M |
| 7 | T1019 | Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant) | $171.68M |
| 8 | 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | $148.23M |
| 9 | T2046 | Hospice long term care, room and board only; per diem | $146.26M |
| 10 | 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $134.85M |
| 11 | 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | $128.97M |
| 12 | H0040 | Assertive community treatment program, per diem | $126.28M |
| 13 | H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | $119.46M |
| 14 | T1015 | Clinic visit/encounter, all-inclusive | $111.21M |
| 15 | G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $95.62M |
| 16 | 99284 | Emergency department visit for the evaluation and management, high severity | $89.90M |
| 17 | T1024 | Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter | $88.60M |
| 18 | 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | $80.83M |
| 19 | S5102 | Day care services, adult; per diem | $77.21M |
| 20 | T2031 | Assisted living; waiver, per diem | $72.25M |
| 21 | 90834 | Psychotherapy, 45 minutes with patient | $70.85M |
| 22 | 99283 | Emergency department visit for the evaluation and management, moderate severity | $64.85M |
| 23 | S5130 | Homemaker service, nos; per 15 minutes | $64.76M |
| 24 | T2003 | Non-emergency transportation; encounter/trip | $58.75M |
| 25 | H0046 | Mental health services, not otherwise specified | $48.72M |
| 26 | T2022 | Case management, per month | $47.26M |
| 27 | T1016 | Case management, each 15 minutes | $42.47M |
| 28 | 90999 | Unlisted dialysis procedure, inpatient or outpatient | $37.10M |
| 29 | T1027 | Family training and counseling for child development, per 15 minutes | $36.48M |
| 30 | G0378 | Hospital observation service, per hour | $35.34M |
| 31 | 90837 | Psychotherapy, 53 minutes with patient | $34.56M |
| 32 | H0047 | Alcohol and/or other drug abuse services, not otherwise specified | $34.20M |
| 33 | T2025 | Waiver services; not otherwise specified (nos) | $32.93M |
| 34 | 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | $32.76M |
| 35 | S5136 | Companion care, adult (e.g., iadl/adl); per diem | $30.60M |
| 36 | H2019 | Therapeutic behavioral services, per 15 minutes | $29.44M |
| 37 | T1000 | Private duty / independent nursing service(s) - licensed, up to 15 minutes | $28.89M |
| 38 | T1005 | Respite care services, up to 15 minutes | $28.23M |
| 39 | 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | $25.32M |
| 40 | G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | $25.32M |
| 41 | T2016 | Habilitation, residential, waiver; per diem | $24.86M |
| 42 | S9123 | Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) | $24.81M |
| 43 | H2014 | Skills training and development, per 15 minutes | $23.97M |
| 44 | H2018 | Psychosocial rehabilitation services, per diem | $22.47M |
| 45 | 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | $21.64M |
| 46 | 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $21.35M |
| 47 | H2001 | Rehabilitation program, per 1/2 day | $19.88M |
| 48 | H0035 | Mental health partial hospitalization, treatment, less than 24 hours | $18.03M |
| 49 | 97150 | Therapeutic procedure(s), group (2 or more individuals) | $17.88M |
| 50 | 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $17.88M |
| 51 | H0004 | Behavioral health counseling and therapy, per 15 minutes | $17.45M |
| 52 | U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $16.86M |
| 53 | H0036 | Community psychiatric supportive treatment, face-to-face, per 15 minutes | $16.69M |
| 54 | T1041 | Medicaid certified community behavioral health clinic services, per month | $16.29M |
| 55 | J1745 | Injection, infliximab, excludes biosimilar, 10 mg | $15.93M |
| 56 | 97530 | Therapeutic activities, direct patient contact, each 15 minutes | $15.01M |
| 57 | S9124 | Nursing care, in the home; by licensed practical nurse, per hour | $14.82M |
| 58 | D1120 | Prophylaxis - child | $14.35M |
| 59 | 99479 | Subsequent intensive care, per day, very low birth weight infant | $14.34M |
| 60 | 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | $13.90M |
| 61 | 80053 | Comprehensive metabolic panel | $13.76M |
| 62 | T1030 | Nursing care, in the home, by registered nurse, per diem | $13.75M |
| 63 | S9122 | Home health aide or certified nurse assistant, providing care in the home; per hour | $13.30M |
| 64 | T2020 | Day habilitation, waiver; per diem | $12.97M |
| 65 | A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | $12.69M |
| 66 | 80048 | Basic metabolic panel (calcium, ionized) | $12.64M |
| 67 | 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | $12.61M |
| 68 | 96375 | Therapeutic injection; each additional sequential IV push | $12.53M |
| 69 | S5135 | Companion care, adult (e.g., iadl/adl); per 15 minutes | $12.45M |
| 70 | S9485 | Crisis intervention mental health services, per diem | $12.37M |
| 71 | 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | $12.33M |
| 72 | 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | $12.09M |
| 73 | D1206 | Topical application of fluoride varnish | $11.61M |
| 74 | 88305 | Level IV - Surgical pathology, gross and microscopic examination | $11.56M |
| 75 | 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | $11.15M |
| 76 | Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | $10.88M |
| 77 | A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $10.65M |
| 78 | 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | $10.62M |
| 79 | 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | $10.52M |
| 80 | 90791 | Psychiatric diagnostic evaluation | $10.19M |
| 81 | T2019 | Habilitation, supported employment, waiver; per 15 minutes | $9.64M |
| 82 | 74177 | Computed tomography, abdomen and pelvis; with contrast material | $9.58M |
| 83 | 90832 | Psychotherapy, 30 minutes with patient | $9.51M |
| 84 | 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | $9.47M |
| 85 | 80061 | Lipid panel | $9.46M |
| 86 | D8670 | Periodic orthodontic treatment visit | $9.29M |
| 87 | 90792 | Psychiatric diagnostic evaluation with medical services | $9.06M |
| 88 | H2016 | Comprehensive community support services, per diem | $8.99M |
| 89 | 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | $8.93M |
| 90 | 36415 | Collection of venous blood by venipuncture | $8.92M |
| 91 | 99282 | Emergency department visit for the evaluation and management, low to moderate severity | $8.92M |
| 92 | 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | $8.81M |
| 93 | 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | $8.64M |
| 94 | 99215 | Prolong outpt/office vis | $8.61M |
| 95 | 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | $8.58M |
| 96 | G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | $8.46M |
| 97 | H2022 | Community-based wrap-around services, per diem | $8.46M |
| 98 | 77067 | Screening mammography, bilateral, including computer-aided detection | $8.24M |
| 99 | 80050 | General health panel | $8.07M |
| 100 | D0120 | Periodic oral evaluation - established patient | $7.92M |
| 101 | H2000 | Comprehensive multidisciplinary evaluation | $7.88M |
| 102 | 84443 | Thyroid stimulating hormone (TSH) | $7.84M |
| 103 | J9271 | Injection, pembrolizumab, 1 mg | $7.74M |
| 104 | G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | $7.60M |
| 105 | 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | $7.59M |
| 106 | D1110 | Prophylaxis - adult | $7.55M |
| 107 | 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | $7.28M |
| 108 | 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | $7.26M |
| 109 | 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | $7.26M |
| 110 | S9131 | Physical therapy; in the home, per diem | $7.24M |
| 111 | J2405 | Injection, ondansetron hydrochloride, per 1 mg | $7.05M |
| 112 | T1001 | Nursing assessment / evaluation | $6.91M |
| 113 | 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | $6.88M |
| 114 | 71046 | Radiologic examination, chest; 2 views | $6.81M |
| 115 | 99232 | Subsequent hospital care, per day, moderate complexity | $6.74M |
| 116 | 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | $6.66M |
| 117 | 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | $6.58M |
| 118 | D7140 | Extraction, erupted tooth or exposed root | $6.54M |
| 119 | 83036 | Hemoglobin; glycosylated (A1C) | $6.49M |
| 120 | T2041 | Supports brokerage, self-directed, waiver; per 15 minutes | $6.48M |
| 121 | 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | $6.37M |
| 122 | D8080 | Comprehensive orthodontic treatment of the adolescent dentition | $6.35M |
| 123 | T2015 | Habilitation, prevocational, waiver; per hour | $6.34M |
| 124 | T1002 | Rn services, up to 15 minutes | $6.33M |
| 125 | 83735 | $6.23M | |
| 126 | 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | $6.15M |
| 127 | A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | $6.14M |
| 128 | 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | $6.08M |
| 129 | T1017 | Targeted case management, each 15 minutes | $5.98M |
| 130 | 96361 | Intravenous infusion, hydration; each additional hour | $5.88M |
| 131 | 81001 | $5.86M | |
| 132 | 99600 | Unlisted home visit service or procedure | $5.82M |
| 133 | J1100 | Injection, dexamethasone sodium phosphate, 1 mg | $5.61M |
| 134 | X0215 | $5.54M | |
| 135 | V2020 | Frames, purchases | $5.53M |
| 136 | Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | $5.49M |
| 137 | 90460 | Immunization administration through 18 years of age via any route, first or only component | $5.44M |
| 138 | 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | $5.43M |
| 139 | 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | $5.40M |
| 140 | 84484 | $5.24M | |
| 141 | J7030 | Infusion, normal saline solution , 1000 cc | $5.12M |
| 142 | 77386 | $5.05M | |
| 143 | D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | $5.04M |
| 144 | J2323 | Injection, natalizumab, 1 mg | $5.01M |
| 145 | V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | $4.88M |
| 146 | J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | $4.82M |
| 147 | J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | $4.80M |
| 148 | H0010 | Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient) | $4.68M |
| 149 | 70450 | Computed tomography, head or brain; without contrast material | $4.67M |
| 150 | H2023 | Supported employment, per 15 minutes | $4.64M |
| 151 | 92015 | Determination of refractive state | $4.59M |
| 152 | 86803 | $4.53M | |
| 153 | 95810 | Polysomnography; sleep staging with 4 or more additional parameters | $4.49M |
| 154 | 82248 | $4.43M | |
| 155 | J2501 | Injection, paricalcitol, 1 mcg | $4.38M |
| 156 | H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | $4.33M |
| 157 | 85027 | $4.32M | |
| 158 | 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | $4.29M |
| 159 | 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | $4.26M |
| 160 | 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | $4.24M |
| 161 | X0377 | $4.21M | |
| 162 | S5170 | Home delivered meals, including preparation; per meal | $4.17M |
| 163 | 76818 | $4.12M | |
| 164 | D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | $4.11M |
| 165 | 87086 | Culture, bacterial; quantitative colony count, urine | $4.11M |
| 166 | 99233 | Prolong inpt eval add15 m | $4.09M |
| 167 | 83690 | $4.08M | |
| 168 | 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | $4.03M |
| 169 | 84100 | $4.03M | |
| 170 | 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | $4.02M |
| 171 | 87428 | $3.97M | |
| 172 | 82728 | $3.95M | |
| 173 | D8660 | $3.90M | |
| 174 | J2350 | Injection, ocrelizumab, 1 mg | $3.90M |
| 175 | T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | $3.84M |
| 176 | 85610 | $3.83M | |
| 177 | J2250 | Injection, midazolam hydrochloride, per 1 mg | $3.80M |
| 178 | 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | $3.77M |
| 179 | J7050 | Infusion, normal saline solution, 250 cc | $3.74M |
| 180 | J3490 | Unclassified drugs | $3.73M |
| 181 | J3010 | Injection, fentanyl citrate, 0.1 mg | $3.72M |
| 182 | 86780 | $3.69M | |
| 183 | T1003 | Lpn/lvn services, up to 15 minutes | $3.63M |
| 184 | D1351 | Sealant - per tooth | $3.62M |
| 185 | 86850 | $3.62M | |
| 186 | T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | $3.56M |
| 187 | 80076 | $3.54M | |
| 188 | H2031 | Mental health clubhouse services, per diem | $3.50M |
| 189 | 92340 | Fitting of spectacles, except for aphakia; monofocal | $3.49M |
| 190 | G0463 | Hospital outpatient clinic visit for assessment and management of a patient | $3.46M |
| 191 | E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | $3.43M |
| 192 | J0690 | Injection, cefazolin sodium, 500 mg | $3.40M |
| 193 | A0425 | Ground mileage, per statute mile | $3.33M |
| 194 | S5161 | Emergency response system; service fee, per month (excludes installation and testing) | $3.27M |
| 195 | D1208 | Topical application of fluoride, excluding varnish | $3.27M |
| 196 | J2704 | Injection, propofol, 10 mg | $3.26M |
| 197 | 59025 | Fetal non-stress test | $3.25M |
| 198 | 76830 | Ultrasound, transvaginal | $3.24M |
| 199 | 96367 | $3.16M | |
| 200 | 86900 | $3.16M |